Although RUVBL1/2 are essential proteins in all eukaryotic cells, independent laboratories have developed small molecule inhibitors of RUVBL1/2 ATPase activity, which have anti-tumor activity in pre-clinical cancer models at well-tolerated doses48,49. This evidence concerns the gene DNAH8 and cancer.